$ANIK
Anika Therapeutics, Inc.

2020 Q4 Form 10-Q Financial Statement

#000117184320007600 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $32.69M $31.69M $29.77M
YoY Change 9.79% 6.72% 10.45%
Cost Of Revenue $15.94M $14.35M $8.649M
YoY Change 84.3% 141.15% 23.54%
Gross Profit $16.75M $17.34M $21.12M
YoY Change -20.73% -26.96% 5.89%
Gross Profit Margin 51.23% 54.72% 70.95%
Selling, General & Admin $15.18M $15.90M $12.24M
YoY Change 24.02% 110.94% 99.67%
% of Gross Profit 90.65% 91.7% 57.95%
Research & Development $7.630M $5.217M $4.080M
YoY Change 87.01% 25.47% 0.49%
% of Gross Profit 45.57% 30.08% 19.32%
Depreciation & Amortization $3.500M $3.500M $1.530M
YoY Change 128.76% 130.26% 3.38%
% of Gross Profit 20.9% 20.18% 7.24%
Operating Expenses $22.81M $21.12M $16.32M
YoY Change 39.77% 80.56% 60.16%
Operating Profit -$6.065M -$7.927M $4.803M
YoY Change -226.28% -165.79% -50.78%
Interest Expense $12.31M -$228.0K $360.0K
YoY Change 3319.44% -147.3% -34.55%
% of Operating Profit 7.5%
Other Income/Expense, Net
YoY Change
Pretax Income -$18.14M -$8.155M $5.160M
YoY Change -451.55% -165.08% -49.95%
Income Tax -$2.480M -$1.700M $1.110M
% Of Pretax Income 21.51%
Net Earnings -$15.66M -$6.411M $4.051M
YoY Change -486.5% -169.68% -47.51%
Net Earnings / Revenue -47.9% -20.23% 13.61%
Basic Earnings Per Share -$1.10 -$0.45 $0.28
Diluted Earnings Per Share -$1.10 -$0.45 $0.28
COMMON SHARES
Basic Shares Outstanding 14.21M 14.21M 14.27M
Diluted Shares Outstanding 14.28M 14.21M 14.62M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.30M $124.8M $184.9M
YoY Change -46.84% -27.94% 16.29%
Cash & Equivalents $95.82M $104.2M $157.5M
Short-Term Investments $2.500M $20.50M $27.50M
Other Short-Term Assets $8.800M $6.200M $4.300M
YoY Change 104.65% 313.33% 126.32%
Inventory $46.21M $47.88M $22.00M
Prepaid Expenses
Receivables $24.10M $23.01M $23.08M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $177.4M $201.9M $234.3M
YoY Change -24.29% -9.8% 15.45%
LONG-TERM ASSETS
Property, Plant & Equipment $50.61M $51.63M $50.78M
YoY Change -0.33% -0.23% -6.15%
Goodwill $8.413M $32.42M $7.694M
YoY Change 9.34% 332.89% -2.0%
Intangibles $91.16M $94.29M $7.585M
YoY Change 1101.81% 1127.75% -17.47%
Long-Term Investments
YoY Change
Other Assets $15.42M $13.23M $7.478M
YoY Change 106.2% 129.58% 52.71%
Total Long-Term Assets $188.2M $214.5M $96.40M
YoY Change 95.24% 123.95% 26.76%
TOTAL ASSETS
Total Short-Term Assets $177.4M $201.9M $234.3M
Total Long-Term Assets $188.2M $214.5M $96.40M
Total Assets $365.6M $416.3M $330.7M
YoY Change 10.55% 30.28% 18.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.984M $6.800M $3.832M
YoY Change 134.45% 151.67% 21.92%
Accrued Expenses $14.60M $24.20M $12.40M
YoY Change 17.74% 184.71% 53.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $200.0K
YoY Change
Total Short-Term Liabilities $36.87M $31.14M $16.28M
YoY Change 126.5% 178.15% 44.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $25.00M $0.00
YoY Change
Other Long-Term Liabilities $1.244M $987.0K $357.0K
YoY Change 248.46% 165.32% -35.09%
Total Long-Term Liabilities $1.244M $25.99M $357.0K
YoY Change 248.46% 6885.75% -35.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.87M $31.14M $16.28M
Total Long-Term Liabilities $1.244M $25.99M $357.0K
Total Liabilities $38.11M $57.13M $16.63M
YoY Change 129.12% 393.87% 40.5%
SHAREHOLDERS EQUITY
Retained Earnings $221.4M $237.1M $245.4M
YoY Change -9.77% -1.77% 12.46%
Common Stock $55.50M $52.65M $48.85M
YoY Change 13.61% 12.92% -4.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $272.4M $284.5M $288.4M
YoY Change
Total Liabilities & Shareholders Equity $365.6M $416.3M $330.7M
YoY Change 10.55% 30.28% 18.54%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income -$15.66M -$6.411M $4.051M
YoY Change -486.5% -169.68% -47.51%
Depreciation, Depletion And Amortization $3.500M $3.500M $1.530M
YoY Change 128.76% 130.26% 3.38%
Cash From Operating Activities $2.590M $5.870M $13.03M
YoY Change -80.12% -41.59% 30.17%
INVESTING ACTIVITIES
Capital Expenditures -$450.0K -$270.0K -$270.0K
YoY Change 66.67% -37.21% 58.82%
Acquisitions
YoY Change
Other Investing Activities $17.25M $7.000M $41.29M
YoY Change -58.22% 176.68% -1806.2%
Cash From Investing Activities $16.81M $6.730M $41.02M
YoY Change -59.02% 220.48% -1689.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -28.11M -25.18M 280.0K
YoY Change -10139.29% -216.04% -660.0%
NET CHANGE
Cash From Operating Activities 2.590M 5.870M 13.03M
Cash From Investing Activities 16.81M 6.730M 41.02M
Cash From Financing Activities -28.11M -25.18M 280.0K
Net Change In Cash -8.710M -12.58M 54.33M
YoY Change -116.03% -137.16% 636.18%
FREE CASH FLOW
Cash From Operating Activities $2.590M $5.870M $13.03M
Capital Expenditures -$450.0K -$270.0K -$270.0K
Free Cash Flow $3.040M $6.140M $13.30M
YoY Change -77.14% -41.41% 30.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14214516
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1055000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
962000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25000000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14208000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14208000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14308000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14308000
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0 USD
us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
1900000 USD
anik Effective Income Tax Rate Reconciliationchange In Fair Value Of Business Acquisition Contingent Consideration Liabilities Amount
EffectiveIncomeTaxRateReconciliationchangeInFairValueOfBusinessAcquisitionContingentConsiderationLiabilitiesAmount
1500000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21367000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12584000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4331000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21132000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104216000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157463000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
20542000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
27480000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23009000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23079000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
47882000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
21995000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6226000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4289000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
201875000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
234306000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51629000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50783000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22898000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22864000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13226000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7478000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
94291000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7585000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
32419000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
7694000 USD
CY2020Q3 us-gaap Assets
Assets
416338000 USD
CY2019Q4 us-gaap Assets
Assets
330710000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6800000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3832000 USD
CY2020Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
24339000 USD
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12445000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
31139000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16277000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
987000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
357000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
41045000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
142000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
143000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
52505000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
48707000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5296000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5898000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
237100000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
245426000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
284451000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
288378000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
416338000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
330710000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31694000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29697000 USD
CY2019Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18144000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97769000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84838000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14351000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5951000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45487000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20098000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5217000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4158000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15799000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12581000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15903000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7539000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44884000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22713000 USD
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4150000 USD
CY2019Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-16176000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
39621000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
17648000 USD
us-gaap Costs And Expenses
CostsAndExpenses
108138000 USD
us-gaap Costs And Expenses
CostsAndExpenses
55392000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7927000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
12049000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10369000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
29446000 USD
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-228000 USD
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
482000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-118000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1513000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8155000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12531000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10487000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30959000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1744000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3331000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2161000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7817000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6411000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
9200000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8326000 USD
us-gaap Net Income Loss
NetIncomeLoss
23142000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.65
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14205000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14070000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14202000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14065000
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.62
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14205000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14387000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14202000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14266000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6411000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
9200000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8326000 USD
us-gaap Net Income Loss
NetIncomeLoss
23142000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
522000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-622000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
602000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-792000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5889000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8578000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7724000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22350000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
288378000 USD
CY2020Q1 anik Apic Sharebased Payment Arrangement Increase Decrease For Cost Recognition Benefit
APICSharebasedPaymentArrangementIncreaseDecreaseForCostRecognitionBenefit
-207000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
141000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
5793000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-129000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
293694000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
68000 USD
CY2020Q2 anik Apic Sharebased Payment Arrangement Increase Decrease For Cost Recognition Benefit
APICSharebasedPaymentArrangementIncreaseDecreaseForCostRecognitionBenefit
2240000 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
59000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7708000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
209000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
288444000 USD
CY2020Q3 anik Apic Sharebased Payment Arrangement Increase Decrease For Cost Recognition Benefit
APICSharebasedPaymentArrangementIncreaseDecreaseForCostRecognitionBenefit
1920000 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
24000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6411000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
522000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
284451000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
263612000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
124000 USD
CY2019Q1 anik Apic Sharebased Payment Arrangement Increase Decrease For Cost Recognition Benefit
APICSharebasedPaymentArrangementIncreaseDecreaseForCostRecognitionBenefit
1386000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
4507000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-315000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
269071000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
852000 USD
CY2019Q2 anik Apic Sharebased Payment Arrangement Increase Decrease For Cost Recognition Benefit
APICSharebasedPaymentArrangementIncreaseDecreaseForCostRecognitionBenefit
1443000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
30000000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
9435000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
145000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
250946000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20967000 USD
CY2019Q3 anik Apic Sharebased Payment Arrangement Increase Decrease For Cost Recognition Benefit
APICSharebasedPaymentArrangementIncreaseDecreaseForCostRecognitionBenefit
1311000 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
120000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
9200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-622000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
281682000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8326000 USD
us-gaap Net Income Loss
NetIncomeLoss
23142000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9963000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4459000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
22000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
-0 USD
anik Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
1136000 USD
anik Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
880000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18144000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-16176000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-287000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-927000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1025000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
303000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3953000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4140000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3302000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2340000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-681000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
222000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
377000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10478000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23983000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
93859000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
27000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
941000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-482000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-450000 USD
us-gaap Inventory Write Down
InventoryWriteDown
4205000 USD
us-gaap Inventory Write Down
InventoryWriteDown
1062000 USD
anik Amortization Of Acquisition Related Inventory Step Up
AmortizationOfAcquisitionRelatedInventoryStepUp
7396000 USD
anik Amortization Of Acquisition Related Inventory Step Up
AmortizationOfAcquisitionRelatedInventoryStepUp
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-3000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
1075000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7811000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2751000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8840000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6600000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
989000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-440000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1904000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-335000 USD
anik Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-1286000 USD
anik Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-796000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
87594000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
20035000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
86368000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1179000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2559000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88073000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1333000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
155000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
-0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
25351000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
50000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
224000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
245000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
68000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21825000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24338000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8420000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
109000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-53247000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14339000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
157463000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89042000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
104216000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
44000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
132000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103381000 USD
anik Consideration For Acquisitions Included In Accounts Payable And Accrued Expenses
ConsiderationForAcquisitionsIncludedInAccountsPayableAndAccruedExpenses
1209000 USD
anik Consideration For Acquisitions Included In Accounts Payable And Accrued Expenses
ConsiderationForAcquisitionsIncludedInAccountsPayableAndAccruedExpenses
0 USD
anik Acquisition Related Contingent Consideration
AcquisitionRelatedContingentConsideration
69076000 USD
anik Acquisition Related Contingent Consideration
AcquisitionRelatedContingentConsideration
0 USD
us-gaap Nature Of Operations
NatureOfOperations
<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;"><tbody><tr><td style="width: 5%; vertical-align: top;"> <p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><b><em style="font: inherit;">1.</em></b></p> </td><td style="vertical-align: top; width: 95%;"> <p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><b>Nature of Business</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b> </b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 27pt; text-align: justify;">Anika Therapeutics, Inc. (“the Company”), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care, including in the areas of osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 27pt; text-align: justify;">In early <em style="font: inherit;">2020,</em> the Company expanded its overall technology platform through its strategic acquisitions of Parcus Medical, LLC (“Parcus Medical”), a sports medicine implant and instrumentation solutions provider focused on surgical repair and reconstruction of ligaments and tendons, and Arthrosurface, Incorporated (“Arthrosurface”), a joint preservation technology company specializing in less invasive joint replacement solutions. These acquisitions broadened Anika's product portfolio into joint preservation and restoration, added high-growth revenue streams, increased its commercial capabilities, diversified its revenue base, and expanded its product pipeline and research and development expertise.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 27pt; text-align: justify;">There continue to be uncertainties regarding the pandemic of the novel coronavirus (“COVID-<em style="font: inherit;">19”</em>), and the Company is closely monitoring the impact of COVID-<em style="font: inherit;">19</em> on all aspects of its business, including how it will impact its customers, employees, suppliers, vendors, and business partners. The Company is unable to predict the impact that COVID-<em style="font: inherit;">19</em> <em style="font: inherit;"> may </em>have on its financial position and operations moving forward due to the numerous uncertainties. Any estimates made herein <em style="font: inherit;"> may </em>change as new events occur and additional information is obtained, and actual results could differ materially from any estimates made herein under different assumptions or conditions. The Company will continue to assess the evolving impact of COVID-<em style="font: inherit;">19.</em></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 27pt; text-align: justify;">The Company is subject to risks common to companies in the biotechnology and medical device industries including, but <em style="font: inherit;">not</em> limited to, development by the Company or its competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, commercialization of existing and new products, and compliance with U.S. Food and Drug Administration (“FDA”) and foreign regulations and approval requirements, as well as the ability to grow the Company’s business through appropriate commercial strategies.</p>
CY2020Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
31694000 USD
CY2019Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
39912000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
101722000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
115045000 USD
CY2020Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-6411000 USD
CY2019Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
4909000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-7328000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
7296000 USD
CY2020Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
5500000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12973000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12058000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12372000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8330000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
35259000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8777000 USD
CY2020Q3 anik Inventory Raw Materials Work In Process And Finished Goods Net Of Reserve Total
InventoryRawMaterialsWorkInProcessAndFinishedGoodsNetOfReserveTotal
60604000 USD
CY2019Q4 anik Inventory Raw Materials Work In Process And Finished Goods Net Of Reserve Total
InventoryRawMaterialsWorkInProcessAndFinishedGoodsNetOfReserveTotal
29165000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
47882000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
21995000 USD
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
12722000 USD
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
7170000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1900000 USD
CY2020Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
118859000 USD
CY2020Q3 anik Accumulated Currency Translation Adjustment
AccumulatedCurrencyTranslationAdjustment
4468000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1025000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19075000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
94291000 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P13Y
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
28206000 USD
CY2019Q4 anik Accumulated Currency Translation Adjustment
AccumulatedCurrencyTranslationAdjustment
4759000 USD
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
-389000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15473000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7585000 USD
CY2019 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P11Y
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
7694000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
7851000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
349000 USD
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-157000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
42520000 USD
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18144000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-0 USD
CY2020Q3 us-gaap Goodwill
Goodwill
32419000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
7694000 USD
us-gaap Number Of Reporting Units
NumberOfReportingUnits
2 pure
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
50000 USD
CY2019Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
136000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 USD
CY2020Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
7000 USD
CY2019Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
22000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
CY2020Q3 anik Finance Lease Expense
FinanceLeaseExpense
57000 USD
CY2019Q3 anik Finance Lease Expense
FinanceLeaseExpense
0 USD
anik Finance Lease Expense
FinanceLeaseExpense
158000 USD
anik Finance Lease Expense
FinanceLeaseExpense
0 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
590000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
525000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1759000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1568000 USD
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
6000 USD
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
67000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
43000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
204000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
155000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
714000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
568000 USD
us-gaap Lease Cost
LeaseCost
2121000 USD
us-gaap Lease Cost
LeaseCost
1729000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y10M24D
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P17Y1M6D
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y10M24D
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P17Y1M6D
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041 pure
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041 pure
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041 pure
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041 pure
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.050 pure
CY2019Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0 pure
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.050 pure
CY2019Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0 pure
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
603000 USD
CY2019Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
488000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1739000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1482000 USD
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
59000 USD
CY2019Q3 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
110000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
598000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
59000 USD
CY2020Q3 anik Operating And Finance Lease Liability To Be Paid Remainder Of Fiscal Year
OperatingAndFinanceLeaseLiabilityToBePaidRemainderOfFiscalYear
657000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2304000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
170000 USD
CY2020Q3 anik Operating And Finance Lease Liability To Be Paid Year One
OperatingAndFinanceLeaseLiabilityToBePaidYearOne
2474000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2240000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
166000 USD
CY2020Q3 anik Operating And Finance Lease Liability To Be Paid Year Two
OperatingAndFinanceLeaseLiabilityToBePaidYearTwo
2406000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2123000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
160000 USD
CY2020Q3 anik Operating And Finance Lease Liability To Be Paid Year Three
OperatingAndFinanceLeaseLiabilityToBePaidYearThree
2283000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2059000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
44000 USD
CY2020Q3 anik Operating And Finance Lease Liability To Be Paid Year Four
OperatingAndFinanceLeaseLiabilityToBePaidYearFour
2103000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1924000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
19450000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2020Q3 anik Operating And Finance Lease Liability To Be Paid After Year Four
OperatingAndFinanceLeaseLiabilityToBePaidAfterYearFour
19450000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8103000 USD
CY2020Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
44000 USD
CY2020Q3 anik Operating And Finance Lease Liability Undiscounted Excess Amount
OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
8147000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21132000 USD
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
391000 USD
CY2020Q3 anik Operating And Finance Lease Liability Non Current
OperatingAndFinanceLeaseLiabilityNonCurrent
21523000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6559000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5830000 USD
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2358000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3850000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1463000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1141000 USD
CY2020Q3 anik Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
910000 USD
CY2019Q4 anik Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
788000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
11855000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
163000 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1031000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
836000 USD
CY2020Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
24339000 USD
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12445000 USD
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31694000 USD
CY2020Q3 anik Percentage Of Net Revenue
PercentageOfNetRevenue
1 pure
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29697000 USD
CY2019Q3 anik Percentage Of Net Revenue
PercentageOfNetRevenue
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97769000 USD
anik Percentage Of Net Revenue
PercentageOfNetRevenue
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84838000 USD
anik Percentage Of Net Revenue
PercentageOfNetRevenue
1 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1920000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1311000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3954000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4140000 USD
CY2020Q1 anik Share Based Compensation Onetime Benefit Expenses For Unexpected Death Of Former President
ShareBasedCompensationOnetimeBenefitExpensesForUnexpectedDeathOfFormerPresident
1800000 USD
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
317000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
201000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14205000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14070000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14202000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14065000
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14205000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14387000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14202000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14266000
CY2019Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000.0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2200000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.214 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.206 pure
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7800000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.253 pure
CY2020Q3 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
1900000 USD
CY2020Q3 anik Effective Income Tax Rate Reconciliationchange In Fair Value Of Business Acquisition Contingent Consideration Liabilities Amount
EffectiveIncomeTaxRateReconciliationchangeInFairValueOfBusinessAcquisitionContingentConsiderationLiabilitiesAmount
1500000 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
500000 USD

Files In Submission

Name View Source Status
0001171843-20-007600-index-headers.html Edgar Link pending
0001171843-20-007600-index.html Edgar Link pending
0001171843-20-007600.txt Edgar Link pending
0001171843-20-007600-xbrl.zip Edgar Link pending
anik-20200930.xsd Edgar Link pending
anik-20200930_cal.xml Edgar Link unprocessable
anik-20200930_def.xml Edgar Link unprocessable
anik-20200930_lab.xml Edgar Link unprocessable
anik-20200930_pre.xml Edgar Link unprocessable
anik20200930_10q.htm Edgar Link pending
anik20200930_10q_htm.xml Edgar Link completed
ex_209675.htm Edgar Link pending
ex_209676.htm Edgar Link pending
ex_209677.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
znbh1rw4aex-31img001.gif Edgar Link pending